|
Report Date : |
27.07.2013 |
IDENTIFICATION DETAILS
|
Name : |
RWANDA
BIOMEDICAL CENTER |
|
|
|
|
Medical Procurement
and Distribution Division (MPD): |
District de Gasabo, Mairie de la Ville de Kigali B.P 640 – Kigali |
|
|
|
|
Country : |
Rwanda |
|
|
|
|
Financials (as on) : |
30.06.2012 |
|
|
|
|
Date of Incorporation : |
25.01.2011 |
|
|
|
|
Legal Form : |
Public authority |
|
|
|
|
Line of Business : |
The centre is engaged in production, procurement and distribution of medicines and commodities for public health facilities. |
|
|
|
|
No. of Employees : |
1,066 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
Slow but correct |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Rwanda |
C1 |
C1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
RWANDA - ECONOMIC OVERVIEW
Rwanda is a poor rural country with about 90% of the
population engaged in (mainly subsistence) agriculture and some mineral and
agro-processing. Tourism, minerals, coffee and tea are Rwanda's main sources of
foreign exchange. Minerals exports declined 40% in 2009-10 due to the global
economic downturn. The 1994 genocide decimated Rwanda's fragile economic base,
severely impoverished the population, particularly women, and temporarily
stalled the country's ability to attract private and external investment.
However, Rwanda has made substantial progress in stabilizing and rehabilitating
its economy to pre-1994 levels. GDP has rebounded with an average annual growth
of 7%-8% since 2003 and inflation has been reduced to single digits.
Nonetheless, a significant percent of the population still live below the
official poverty line. Despite Rwanda's fertile ecosystem, food production
often does not keep pace with demand, requiring food imports. Rwanda continues
to receive substantial aid money and obtained IMF-World Bank Heavily Indebted
Poor Country (HIPC) initiative debt relief in 2005-06. In recognition of
Rwanda's successful management of its macro economy, in 2010, the IMF graduated
Rwanda to a Policy Support Instrument (PSI). Rwanda also received a Millennium
Challenge Threshold Program in 2008. Africa's most densely populated country is
trying to overcome the limitations of its small, landlocked economy by
leveraging regional trade. Rwanda joined the East African Community and is
aligning its budget, trade, and immigration policies with its regional
partners. The government has embraced an expansionary fiscal policy to reduce
poverty by improving education, infrastructure, and foreign and domestic
investment and pursuing market-oriented reforms. Energy shortages, instability
in neighboring states, and lack of adequate transportation linkages to other
countries continue to handicap private sector growth. The Rwandan government is
seeking to become regional leader in information and communication
technologies. In 2010, Rwanda neared completion of the first modern Special
Economic Zone (SEZ) in Kigali. The SEZ seeks to attract investment in all
sectors, but specifically in agribusiness, information and communications
technologies, trade and logistics, mining, and construction. The global
downturn hurt export demand and tourism, but economic growth has recovered,
driven in large part by the services sector, but inflation has grown. On the
back of this growth, government is gradually ending its fiscal stimulus policy
while protecting aid to the poor.
Source
: CIA
Rwanda Biomedical
Center
DBA: RBC
ADDRESSES:
Zip code/City: Rwanda
Medical procurement and distribution
division (MPD)
District de Gasabo,
Mairie de la Ville de Kigali
B.P 640 – Kigali
– Rwanda
Telephone: +250 580156
+250
580157
Fax: +250
582725
Email: camerwa@gmail.com
Web site: http://www.rbc.gov.rw/
Profile
Established: 2011
Banks: Rwanda
Commercial Bank, P.O. Box 354, Kigali
Employees: 1,066
CNPJ: -
Board of
Directors:
General Director Dr. Pierre Claver
Kayumba
Public
information:
Legal form: Public
authority
Incorporation
date: 25.01.5201
Balance sheet
filing date: -
Tax Contributor
Number (CNPJ): -
Legal status: active
Entry Deleted Name
25.01.2011 Rwanda Biomedical Center
Import and
Export:
Import
Payment history:
No complaints on record.
Financial Data
Rwanda Biomedical Center
Consolidation: unconsolidated
Industry: Trade/Industry
Fiscal year end: 30.06.2012
Number of months: 12
Currency:
RWF
Balance Sheet
Trade accounts receivable 4,137,695,849,0
Liquid assets 14,576,190,361,0
Other current assets 14,576,190,361,0
Current assets 18,713,886,210,0
Total shareholders equity 6,021,429,434,0
short term debt (financial debts) 12,692,456,776,0
Current liabilities 12,692,456,776,0
Shareh. equity, min.
interests + liabilities 18,713,886,210,0
Profit and loss
account
Sales 43,833,730,245,0
Net sales 43,833,730,245,0
Operating revenue 43,833,730,245,0
Gross profit 43,833,730,245,0
Other operating expenses 43,933,941,842,0
Operating result -100,211,597,0
Result before extraordinary items -100,211,597,0
Extraordinary Result 0,0
Result before taxes -100,211,597,0
Result before minority interests -100,211,597,0
Result for the financial year -100,211,597,0
Financial
information:
Breakdown of the budget over the various divisions
for 2011/2012:
RBC/MMC: RWF 209,386,097
RBC/RHCC: : RWF 583,272,408
RBC/MOPDD : RWF 16,597,683
RBC/NRL : RWF 21,614,756
RBC/KFH: RWF 7,398,394,794
RBC/MPD: RWF 7,083,009,266
RBC/MP : RWF 40,086,857
RBC/IM : RWF 16,022,398
RBC/VPDD : RWF 33,783,000
Other : RWF 58,226,579
Total: RWF 15,368,384,259
Source of revenue 2011/2012:
Cash transfers from Treasury & Direct Payment:
RWF 6,147,767,724
Inter-entity transfers (transfers from other Budget
Agencies): RWF 15,411,775,032
Grants/loans from development partners : RWF
7,483,896,297
Other income (Including internally generated): RWF
14,790,291,192
Total Revenues: RWF 43,833,730,245
Exchange rate:
US$
1,00 =
RWF 637,386 - Official rate on 26.07.2013
Main Activities:
The centre is engaged in production, procurement and
distribution of medicines and commodities for public health facilities.
The mission is to protect and promote public health
by ensuring availability of quality, cost effective, safe and effective use of
medicines, food, cosmetics and medical devices to the population. There are
around 330 pharmacists in Rwanda, distributed in both public, private and NGOs
in the country. Most of Pharmacists are deployed in Private Retail Pharmacies
(87), Private Whole Sales (42), NGOs (28), District Hospitals (40), District
Pharmacies (30), RBC (12), NUR (10), RAMA (17), MMI (1), Government (9).
Operation of 5 blood centres (under acronym
RBC/MPPD/NCBT) located in Kigali, Huye, Musanze, Rwamagana
andKarongi.
Staff:
1,066
Company's
Background:
The Rwanda Biomedical Center was established in
January 2011 by law no54/2010.
Functions as per the law for subject matter are:
Functions are:
1. To coordinate and improve research activities in
the field of disease prevention, education and provision of treatment to people
at all levels;
2. To enable Rwanda to participate in the vital
regional and global health activities, that it is beneficial to all people
living in Rwanda;
3. To act as a biomedical center in the region;
4. To coordinate various biomedical and research
activities with a view to
generating income in health activities;
5. To provide Rwanda with a vision and coordinate
joint activities of various organs in the fight against HIV/AIDS and other
diseases;
6. To coordinate activities geared towards
treatment, control and management of
consequences of HIV and AIDS and other contagious
and non contagious
diseases;
7. To put at the disposal of all people living in Rwanda
drugs and medical
equipments;
8. To provide highly classified medical expertise;
RBC/MPPD cocnerns the Medical Production and
Procurement Department of subject matter.
Credit to the recommended limit should be acceptable
but should be monitored on a regular basis. However, it is accepted practice to
seek (bank) guarantees when dealing with Rwandan importers.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.58.91 |
|
|
1 |
Rs.90.68 |
|
Euro |
1 |
Rs.78.22 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.